chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a healthcare worker via a company representative reported that an unspecified doctor in their office stated that his daughter's friend (female, age unknown) who on an unspecified date was vaccinated with GARDASIL (dose, route and lot # not reported). It was unknown which of the three-doses in the series was received by the patient, and if the GARDASIL series was completed. On an unspecified date after receiving GARDASIL, the patient experienced a seizure. It was reported that the patient was no longer able to drive and also had other unspecified incapacities after the event occurred. The outcome of the adverse event was unknown. The healthcare worker considered the event to be significant disability or incapacity. Upon internal review, seizure was considered to be medically significant. Additional information has been requested.
01/09/2022, in the mid- morning early afternoon the symptoms, I had chest congestion on my chest, cough, and headache. I kept testing positive for omicron. I tested positive for Omicron after my booster shot. I finally tested negative for omicron on Jan 18, 2022. I missed work. Jan 12, I did a home test it was positive. Jan 16, I was still positive. On the 18/2022, negative. I went back to work on the Jan 19, 2022. I still have the headache from the omicron it comes on and off.
pt recvd vax & exp sore lt upper arm, area on lt deltoid red, warm to the touch, measures 5cm x 5cm; DPH given instructed wamr pack site; pt c/o also having fever, chills, n&v, diarrhea & h/a since 8MAR94; pt may have been exposed to flu;
Patient reported to the pharmacy that she had a pop and swelling in the bicep of the same arm that she had a shot and thought the shot contributed.  Advised the patient to go to urgent care for follow up.
Fever 102-103. Localised induration 3-cm. Redness - 5-6 cm.
Headache, body aches, fever, fatigue, joint pain.  Resolved in 24/36 hours
Didn't have any adverse reactions until after a year, but began to have noticeable heart palpitations that triggered an alarm on my fitness watch as abnormal heart-beats.  I went through several tests as the alarms were happening fairly frequently and I was becoming short of breath and very tired as my heart was having extra beats and off rhythms, etc.  It was later determined that my Thyroid is under-active and possibly what was triggering the heart-palpitations.  I've been on a low dose of Levothyroxine that seems to be eliminating the heart-rate spikes.
Additional information received 07/24/02 from physician reported the serotype is 33 (not a Prevnar serotype) Additional information received 07/17/02 from the reporter includes  name and address of patient and dates of immunizations of concomitant vaccine. Additional information received 07/16/02 from the reporter that include dates of 3 Prevnar immunizations and corresponding lot numbers. A physician reported via a compamy representative that an 8 month old female received a 3rd dose of Prevnar (pneumococcal 7-valent conjugate vaccine), Comvax, (Merck), DTAP (Aventis) (diptheria and tetanus toxoids/acellular pertussis vaccine adsorbed) and Polio Vaccine Pasteur (poliomyelitis vaccine inactivated) vaccines on 05/08/02. On 07/13/02, the infant developed fever and was taken to the ER. A blood culture was performed with positive results for pneumococcal bacteria. She was treated with ceftriaxone sodium (Rocephin). On 07/16/02, she was seen by her health care provider and prescribed amoxycillin sodium and potassium clavulanate (Augmentin)
DIZZY; MASSIVE HEADACHE/WORST HEADACHE ONLY ON RIGHT SIDE OF THE HEAD; This spontaneous report received from a consumer by a Business partner   was received on 07-MAY-2021 and concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 2021, the subject experienced dizzy. On 2021, the subject experienced massive headache/worst headache only on right side of the head. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the massive headache/worst headache only on right side of the head and dizzy was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as case assessed as non serious.
A few hours post injection I had arm pain which is typical and expected. Here we are 2+ weeks out and the upper right arm muscle is so sore. I have weakness and pain if and when I extend my arm to reach for anything. Reaching for a glass in the cupboard, something in the fridge or anything where I use my right arm and attempt to grab something. It feels very weak and hurts. a lot. It feels as though whatever muscle is the far outside of my upper right arm is pulled or bruised somehow.
This is a spontaneous report from a contactable consumer reported for himself. A 37-years-old male patient received second dose of bnt162b2 (Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in Arm Left on 25May2021 at 11:00 as dose 2, single (at age of 37-years old) for COVID-19 immunization. Concomitant medication included sertraline hydrochloride (ZOLOFT). The patient previously took first dose of bnt162b2 (Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered on an unspecified date as single dose for COVID-19 immunization, and there was no reaction on previous exposure to drug. The patient had drug allergy to omeprazole (PRILOSEC). The patient did not receive any other vaccine within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient not tested for COVID-19. On 01Jun2021 at 12:00 AM, the patient experienced hearing loss in right ear, right upper stomach pain, fever, chills, cough, and congestion. No treatment was received for all events. The outcome for all events was not resolved. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Immediate swelling at injection site of Hib vaccine. Cold compress applied in office. She call that night, still red at site, not painful will recheck at next appt. No mention of swelling or symptoms at next visit 11/12/13.
This spontaneous report was received from a pharmacist refers to an 82 year old female patient. Patient's pertinent medical history and drug reactions/ allergies were not reported. On 10-JUN-2015 the patient was vaccinated with ZOSTAVAX, 0.65 ml, once, subcutaneous (Lot # L008357, expiry date; 11-JUN-2016). Concomitant medications were unspecified. Following the administration of ZOSTAVAX, the patient developed extreme swelling (an area as big as a baseball), redness and itching at the injection site on 11-JUN-2015. Patient sought medical attention on an unspecified date and was seen in the pharmacy. Lab diagnostic studies were unspecified. Reporting pharmacist stated that the patient was treated with ice application at the injection site along with an unspecified dose of BENADRYL. Action taken with ZOSTAVAX was not reported. Outcome of the events were reported as not recovered. Reporting pharmacist did not provide the causal relationship between the events and the suspect product, ZOSTAVAX. Additional information has been requested.
Pt presents to clinic two days after receiving both the flu and pneumococcal vaccines at the same time in the right arm.  Pt presents with right arm pain which manifested within a few hours of receiving the shots.  Pt noted redness and swelling of the arm (20cm diameter) and general 'ill' feeling (fever and chills).  Pt also experienced some exacerbation of asthma with coughing.  Pt took 25-50mg diphenhydramine which helped a great deal with the redness.  Coughing is resolving.  No other treatment at this time.  Pt has had the flu shot in the past with no adverse reactions.
Rash above the clavicle/scapula between the shoulder and neck. Includes redness, and about 7 or 8 spots resembling bug bites. Entire area was itchy for two days, especially the spots. It is the third day now, and the area is less itchy, the redness has faded and the spots have started to shrink.
BUD date excursion. BUD date 4-7-23 and vaccine was administered 4-21-23.
100% blood clot in LAD  causing heart attack. Had emergency cardiac cath with clot evacuation and stent insertion.
Persistent itching and burning began about one week after injection. The injection was given in a tattooed area of skin (full sleeve tattoo) and the lines of the tattoo became raised and irritated early on and is very uncomfortable.
Headache, Fever, CoughWheeze, NauseaVomiting, NASAL CONGESTION, rib pain Narrative: Tested for covid and was negative
Itchy, Chest pressure on a scale of 1-10 rated a 3 down to a 2 after 2 minutes.  Nausea and lightheaded   Requested EMS to evaluate so EMS was called and Allergist presented.  Remained stable throughout entire event.  Allergist recommended triptophase  lab be drawn to ensure that this was an actual allergic reaction.  This was particularly to prepare for 2nd dose.  Because of this patient was transported to ED and discharge within a few hours.
Patient had some bleeding in her arms and her arms also started to swell within a couple of minutes of the shot. She started to feel chills, light-headedness, and her chest started to turn red. "911" was called and paramedics came shortly and brought her to the hospital.
fever; severe body aches; chills; consistent headache; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 13May2021 at 12:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included depression and anxiety. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 21Apr2021 at 09:30 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 at 02:00, the patient experienced fever, severe body aches, chills and consistent headache. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever, severe body aches, chills and consistent headache were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Information has been received from a healthcare worker concerning a currently 39 years old female with no pertinent medical history and no drug reactions/allergies who in approximately 1973 (when she was 12 months old), was vaccinated with one quarter of a dose of MMR II (HSA, lot # not reported). In April 1973 (38 years ago), the patient experienced swollen fontanels and encephalitis and was hospitalized. Length of hospitalization and treatment was not available at this time. It was unknown if additional MMR II was administered. On 29-MAR-2011, a titer was negative for mumps. The outcome of swollen fontanels, encephalitis and negative titer for mumps was unknown at the time of this report. The patient sought unspecified medical attention for negative titer for mumps. Swollen fontanels and encephalitis were considered to be immediately life-threatening. Additional information has been requested.
Apparently healthy 13 montly old fraternal male twin received vaccines (see below) at approximately 9AM on 11/2/06.  Approximately 12 hours later child experienced seizure at home.  EMT came to home and gave Versed to patient at about 10:30PM and child was brought to ER.  Temp at ER 101.8 (rectal).  At about 11:15PM child experienced respiratory failure, attempte was made to intubate; child pronounced dead at approximately 12:02AM on 11/3/06.  2/22/07 Received autopsy report which reveals COD as complications of midazolam administration following a s/p vaccination benign febrile seizure.
herpes zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications.    On or about 07-JUL-2010, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, and route of administration not specified), as prescribed and/or administered by a healthcare provider at a pharmacy, for the long-term prevention of herpes zoster or shingles.  On an unspecified date, reported as subsequent to patient's zoster vaccine live (ZOSTAVAX) inoculation, the patient was treated by a healthcare provider at a physician's office for herpes zoster. As a direct and proximate result of patient's use of the zoster vaccine live (ZOSTAVAX)  vaccine, the patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; significant medical and related expenses as a result of these injuries, including but not limited to costs for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages. The outcome of the event is not recovered. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
Approximately 5-10 min after giving vaccines, student was sitting down in waiting area when he lost consciousness and his body and extremities started jerking for approx 5-7 seconds. He was then laid down on floor where he regained consciousness and became alert and oriented x3. HR@ 80 reg, B/P120/70.  911 called and student was transferred to Hospital.
Next day patient experienced sweating, pain, drawing up of hands, as well as other symptoms. Pt has continued to have pain that has been untreatable locally. Being referred to clinic. He said hospital/Dr didn't report vaccine adverse event.
Patient is a 71 y.o. female patient of MD with lymphoma, breast cancer with known metastasis to lung and bone presented to Hospital from ER with A-fib with RVR and positive COVID.   New onset A-fib with RVR In the setting of COVID infection Heart rate was 126 on admission, now converted to sinus rhythm Continue Coreg, uptitrate as blood pressure and heart rate tolerate TSH within normal limits Echo pending Cardiology to see outpatient Started on Eliquis this hospitalization     Covid-19 Virus Infection Date of onset of symptoms: 9/27/2023 Symptoms present on admission: Yes Date of covid positive test: 9/28/2023 Vaccination status: vaccinated 1 dose Imaging: CT Oxygen requirements on admission: Yes Current oxygen requirements: 2 L, baseline Medical therapy: remdesivir, steroids Consultants following: ID Anticipated special isolation end date: 10/7/2023 We will see if would be eligible for Paxlovid with ID Discontinue azithromycin and ceftriaxone given no increased oxygen requirements or consolidation on CT chest Continue steroids on discharge Lymphoma Breast cancer, metastatic With metastasis to lung and bone Consult oncology, recommendations appreciated Per oncology hold acalabrutinib and abemaciclib while admitted with acute illness given potential for myelosuppression in the setting of active infection with COVID-19 Continue home letrozole Patient to follow-up outpatient with her primary oncologist before resuming   Chronic oxygen use 2/2 breast cancer metastasis Home oxygen 2 L
Patient seen in ER on 11-4-16 and pronounced dead - possible SIDS. She was seen by us on 10-24-16 and given vaccinations - awaiting ME report.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date the patients were vaccinated with RECOMBIVAX HB. Dose, route, lot number and expiration date were not reported. The nurse reported that doses of RECOMBIVAX HB were stored improperly and administered to an unspecified number of patients on unspecified dates. No adverse effects were reported. This is one of several reports from the same source. Additional information is not expected since we can not contact physician.
Patient was feeling hot and was cooling himself. He got up to get water and passed out not remembering that he had fell. He was taken to be seated with feet elevated to help increase blood flow.
Anaphylactic reaction; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the parent.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ANAPHYLACTIC REACTION (hospitalization), outcome "unknown", described as "Anaphylactic reaction". The lot number for bnt162b2 was not provided and will be requested during follow up.
Initial information was received on 02 March 2009 from a health care professional. A 15 year old female received an intramuscular left arm injection of MENACTRA (lot number U2621AA) on 16 August 2008 while she was pregnant. She had no illness at the time of vaccination, no prior pregnancies, no treatments for infertility, and her date of last menstrual period had been 15 June 2008. She had an ultrasound performed on 20 November 2008 with normal results. The female had a vaginal delivery at 38 weeks gestation on 08 January 2009. The baby boy weighed 5 pounds 1 ounce at birth. The baby was born with an extra left digit. There were no complications during the labor or delivery. No further information was provided. Recovery status was not reported. A case was created for the mother which is captured in case number 2008-02644. List of Documents held by sender: none.
I previously had tinnitus from either contracting Covid or from the first two Moderna vaccine shots in January/ February, 2021.  Until the booster shot on 5/13/2022 the ringing in my ears was 3-4 on a scale of 10. and something manageable.  Since the booster shot on 5/13/2022 the ringing is now more like a 7-8 on the 10 point scale and has become very distracting.
Pt received TIV + Pneumovax on 03 DEC 10. ADM to Hospital for pyelo on 05 DEC.  Pain, tenderness, swelling and red blotches involving the entire outside left upper arm were noted.  At DC on 08 DEC 10 RXN had largely resolved.
Confirmed with imms nurse, my son received ProQuad to the right thigh - Since vaccination, over the course of 1 week, his vaccine site swelled and became indurated and redness spread across his right thigh. Red, not itchy, but tender. Approximately, covered 2/3 of anterior aspect of his thigh.
Arm sore; Initial information received on 13-Oct-2021 regarding an unsolicited valid non-serious case from a social media via consumer/non-health care professional.  This case involves a patient (unknown demographics) who had arm sore (pain in extremity) after receiving INFLUENZA VACCINE.  The patient had no medical history, concomitant disease or risk factor.  The patient's medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included DUPILUMAB (DUPIXENT).  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious arm sore (pain in extremity) (unknown latency) following the administration of INFLUENZA VACCINE.  It was unknown if the patient experienced any additional symptoms/events.  No laboratory data was reported.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome of the event was unknown.  There will be no information available on the batch number for this case.
I had headaches for about 4 months after contacting COVID-19 in December of 2021 only on the right side of my head. I also experienced a feeling as if I was going to pass out or as if I was slightly intoxicated. That has persisted after COVID-19. Some days are good, and some days are bad in terms of having that feeling. Sometimes it lasts all day, sometimes I don't have it, sometimes I have it periodically. I recently followed up with my neurologist. I've had three ambulatory EEGs and they have not shown anything. I asked him what he thought, he said, the problem is that there is no real test for it. I thought it might be that I was dehydrated, but I am not. It doesn't seem to be related to physical position. So, I don't know what it is. I'm still being monitored by my neurologist and in January, I will have another EEG.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 69-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Sep2022 as dose 5 (booster), single (Lot number: 6H9703) for covid-19 immunisation; BNT162b2 (BNT162B2), in Mar2022 as dose 4 (booster), single (Lot number: FK9729) for covid-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history included: "NSCLC" (unspecified if ongoing), notes: NSCLC; "Known allergies: Sulfa" (unspecified if ongoing). Concomitant medication(s) included: ERLOTINIB, start date: Mar2022.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Feb2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid from9Feb2023 to 13feb2023.
Patient experienced dizziness and fainted after vaccination. She reported that she has a fear of needles and stated she did not eat anything prior to vaccination. EMT was called and checked her vitals (blood pressure, blood glucose) upon arousing patient.
About 30 hours after vaccination I have developed red  welts under my armpit and on opposite side of arm from injection,  The welts are sore to the touch, much like the injection site.